GW Henssler & Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,159
Closed -$244K 203
2025
Q1
$244K Sell
2,159
-197,606
-99% -$21.1M 0.01% 150
2024
Q4
$21.6M Sell
199,765
-1,739
-0.9% -$187K 1.24% 33
2024
Q3
$21.8M Buy
201,504
+218
+0.1% +$23.8K 1.23% 33
2024
Q2
$21.8M Sell
201,286
-2,775
-1% -$327K 1.31% 30
2024
Q1
$26.9M Buy
204,061
+10,764
+6% +$1.34M 1.58% 19
2023
Q4
$23.5M Sell
193,297
-14,098
-7% -$1.57M 1.55% 23
2023
Q3
$23.3M Sell
207,395
-1,957
-0.9% -$249K 1.59% 20
2023
Q2
$30.5M Buy
209,352
+5
+0% +$679 2% 8
2023
Q1
$27M Buy
209,347
+57,957
+38% +$7.28M 1.8% 11
2022
Q4
$19.3M Buy
151,390
+3,300
+2% +$383K 1.36% 29
2022
Q3
$15.5M Buy
148,090
+16,538
+13% +$1.81M 1.16% 37
2022
Q2
$13.8M Sell
131,552
-14,855
-10% -$1.76M 1.03% 42
2022
Q1
$18.7M Buy
+146,407
New +$17.6M 1.14% 35
2015
Q4
Sell
-88,243
Closed -$8.05M 179
2015
Q3
$8.05M Buy
88,243
+15,942
+22% +$1.6M 0.92% 48
2015
Q2
$7.67M Buy
72,301
+50,021
+225% +$5.53M 0.83% 57
2015
Q1
$2.54M Buy
+22,280
New +$2.54M 0.29% 91

Other funds holding ZBH

GW Henssler & Associates's ZBH Position: Q2 2025 in Review

GW Henssler & Associates sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,159 shares — an estimated $244K sold.

GW Henssler & Associates first reported a position in ZBH in Q1 2015 and held it in 16 quarters. The position peaked at $30.5M in Q2 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • GW Henssler & Associates reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • GW Henssler & Associates sold 2,159 Zimmer Biomet shares in Q2 2025, an estimated $244K.
  • GW Henssler & Associates first reported a position in Zimmer Biomet in Q1 2015 and held it in 16 quarters.
  • GW Henssler & Associates's Zimmer Biomet position peaked at $30.5M in Q2 2023.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on GW Henssler & Associates's 13F filing for Q2 2025, filed 25 Jul 2025.